Viridian Therapeutics, Inc.

This study tested an investigational drug called veligrotug in 188 people with chronic thyroid eye disease, a condition that causes eye bulging and discomfort. The goal was to see if the drug could safely reduce eye bulging compared to a placebo. The drug works by blocking a spec…

This study tested an investigational drug called VRDN-001 in 143 adults with thyroid eye disease who did not respond to their initial treatment in earlier studies. The drug aims to reduce eye swelling and bulging by blocking a specific receptor. The goal was to see if it could sa…

This study tested a drug called VRDN-001 in 231 people with thyroid eye disease, a condition that causes eye swelling and bulging. The drug works by blocking a receptor linked to inflammation. The main goal was to check safety and how well people tolerate the treatment.